Positive correlation between inhibitors of matrix metalloproteinase 1 and matrix metalloproteinases in malignant ovarian tumor tissues

Cancer Letters

Volumn 120, Issue 1, 1997, Pages 109-115

  Kikkawa, Fumitaka ^a   Tamakoshi, Koji ^a   Nawa, Akihiro ^a   Shibata, Kiyosumi ^a   Yamagata, Sadako ^b   Yamagata, Tatsuya ^b   Suganuma, Nobuhiko ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Matrix metalloproteinase; Ovarian cancer; Tissue inhibitor of metalloproteinase; Zymography

Indexed keywords

COLLAGENASE; GELATINASE A; GELATINASE B; METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; OVARY CANCER; OVARY TUMOR; PHENOTYPE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; COLLAGENASES; FEMALE; GELATINASES; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; MIDDLE AGED; OVARIAN NEOPLASMS; OVARY; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 0030732146     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00295-4     Document Type: Article

References (27)

1. Lyons J.G., Birkedal-Hansen B., Pierson M.C., Whitelock J.M., Birkedal-Hansen H. Interleukin-1β and transforming growth factor-α/epidermal growth factor induce expression of Mr 95 000 type IV collagenase/gelatinase and interstitial fibroblast-type collagenase by rat mucosal keratinocytes. J. Biol. Chem. 268:1993;19143-19151.
2. Nakajima M., Lotan D., Baig M.M., Carralero R.M., Wood W.R., Hendrix M.J.C.et al. Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells. Cancer Res. 49:1989;1698-1706.
3. Agarwal C., Hembree J.R., Rorke E.A., Eckert R.L. Transforming growth factor β1 regulation of metalloproteinase production in cultured human cervical epithelial cells. Cancer Res. 54:1994;943-949.
4. Stetler-Stevenson W.G., Brown P.D., Onisto M., Levy A., Liotta L.A. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J. Biol. Chem. 265:1990;13933-13938.
5. Goldberg G.I., Marmer B.L., Grant G.A., Eisen A.Z., Wilhelm S., He C. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteinases designated TIMP-2. Proc. Natl. Acad. Sci. USA. 86:1989;8207-8211.
6. Khokha R., Waterhouse P., Yagel S., Lala P.K., Overall C.M., Norton G.et al. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science. 243:1989;947-950.
7. Autio-Harmainen H., Karttunen T., Hoyhtya M., Kauppia A., Tryggvason K. Expression of 72 kilodalton type IV collagenase (gelatinase A) in benign and malignant ovarian tumors. Lab. Invest. 69:1993;312-321.
8. McDonnell S., Matrisian L.M. Stromelysin in tumor progression and metastasis. Cancer Metastasis Rev. 9:1990;305-319.
9. Miyagi E., Yasumitsu H., Hirahara F., Minaguchi H., Koshikawa N., Miyazaki K.et al. Characterization of matrix-degrading proteinases and their inhibitors secreted by human gynecological carcinoma cells. Jpn. J. Cancer Res. 86:1995;568-576.
10. Tamakoshi K., Kikkawa F., Nawa A., Maeda O., Kawai M., Suganuma N.et al. Different pattern of zymography between human gynecologic normal and malignant tissues. Am. J. Obstet. Gynecol. 171:1994;478-484.
11. Hoyhtya M., Fridman R., Komarek D., Porter J.K., Stetler-Stevenson W.G., Liotta L.A.et al. Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissues with monoclonal antibodies. Int. J. Cancer. 56:1994;500-505.
12. Naylor M.S., Stamp G.W., Davies B.D., Balkwill F.R. Expression and activity of MMPs and their regulators in ovarian cancer. Int. J. Cancer. 58:1994;50-56.
13. Nuovo G.J., MacConnell P.B., Simsir A., Valea F., French D.L. Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma. Cancer Res. 55:1995;267-275.
14. Richard C.D., Shoyab M., Brown T.J., Gauldie J. Selective regulation of metalloproteinase inhibitor (TIMP-1) by oncostatin M in fibroblasts in culture. J. Immunol. 150:1993;5596-5603.
15. Overall C.M., Wrana J.L., Sodek J. Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. J. Biol. Chem. 266:1991;14064-14071.
16. Kurogi T., Nabeshima K., Kataoka H., Okada Y., Koono M. Stimulation of gelatinase B and tissue inhibitors of metalloproteinase (TIMP) production in co-culture of human osteosarcoma cells and human fibroblasts: gelatinase-B production was stimulated via up-regulation of fibroblast growth factor (FGF) receptor. Int. J. Cancer. 66:1996;82-90.
17. Shimizu S., Nishikawa Y., Kuroda K., Takagi S., Kozaki K., Hyuga S., Saga S., Matsuyama M. Involvement of transforming growth factor b1 in autocrine enhancement of gelatinase B secretion by murine metastatic colon carcinoma cells. Cancer Res. 56:1996;3366-3370.
18. Rao J.S., Steck P.A., Mohanam S., Stetler-Stevenson W.G., Liotta L.A., Sawaya R. Elevated levels of Mr 92,000 type IV collagenase in human brain tumors. Cancer Res. 53:1993;2208-2211.
19. Stetler-Stevenson W.G. Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev. 9:1990;7262-7268.
20. Goldberg G.I., Marmer B.L., Gregory G.A., Eisen A.Z., Wilhelm S., He C. Human 7d2-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteinases designated TIMP-2. Proc. Natl. Acad. Sci. USA. 86:1989;8207-8211.
21. Wilhelm S.M., Collier I.E., Marmer B.L., Eisen A.Z., Grant G.A., Goldberg G.I. SV-40 transformed human lung fibroblasts secrete a 92 kDa type IV collagenase which is identical to that secreted by normal human macrophages. J. Biol. Chem. 264:1989;17213-17217.
22. Lu X., Levy M., Weinstein B., Santella R.M. Immunological quantitation of levels of tissue inhibitor of metalloproteinase-1 in human colon cancer. Cancer Res. 51:1991;6231-6235.
23. Zucker S., Lysik R.M., DiMassimo B.I., Zarrabi H.M., Moll U.M., Grimson R., Tickle S.P., Docherty A.J. Plasma assay of gelatinase B: tissue inhibitor of metalloproteinase complexes in cancer. Cancer. 76:1995;700-708.
24. Takemura M., Azuma C., Kimura T., Kanai T., Saji F., Tanizawa O. Type-IV collagenase and tissue inhibitor of metalloproteinase in ovarian cancer tissues. Int. J. Gynecol. Obstet. 46:1994;303-309.
25. Visscher D.W., Hoyhtya M., Ottosen S.K., Liang C.M., Sarkar F.H., Crissman J.D.et al. Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int. J. Cancer. 59:1994;339-344.
26. Lokeshwar B.L., Selzer M.G., Block N.L., Gunja-Smith Z. Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in explant cultures: reduced tissue inhibitor of metalloproteinase secretion by malignant tissues. Cancer Res. 53:1993;4493-4498.
27. Nuovo G.J., MacConnell P.B., Simsir A., Valea F., French D.L. Correlation of the in situ detection of polymerase chain-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma. Cancer Res. 55:1995;267-275.